339 related articles for article (PubMed ID: 34683861)
1. Emerging Treatment Strategies for Diabetes Mellitus and Associated Complications: An Update.
Mishra V; Nayak P; Sharma M; Albutti A; Alwashmi ASS; Aljasir MA; Alsowayeh N; Tambuwala MM
Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683861
[TBL] [Abstract][Full Text] [Related]
2. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
Ozawa H; Murai Y; Ozawa T
Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
[TBL] [Abstract][Full Text] [Related]
3. Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention.
Tan SY; Mei Wong JL; Sim YJ; Wong SS; Mohamed Elhassan SA; Tan SH; Ling Lim GP; Rong Tay NW; Annan NC; Bhattamisra SK; Candasamy M
Diabetes Metab Syndr; 2019; 13(1):364-372. PubMed ID: 30641727
[TBL] [Abstract][Full Text] [Related]
4. Type II diabetes mellitus: a review on recent drug based therapeutics.
Padhi S; Nayak AK; Behera A
Biomed Pharmacother; 2020 Nov; 131():110708. PubMed ID: 32927252
[TBL] [Abstract][Full Text] [Related]
5. Hyperbaric oxygen therapy for non-healing ulcers in diabetes mellitus: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(11):1-28. PubMed ID: 23074462
[TBL] [Abstract][Full Text] [Related]
6. New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.
Braunstein S
Clin Ther; 2003 Jul; 25(7):1895-917. PubMed ID: 12946541
[TBL] [Abstract][Full Text] [Related]
7. New strategies for basal insulin treatment in type 2 diabetes mellitus.
Dailey G
Clin Ther; 2004 Jun; 26(6):889-901. PubMed ID: 15262459
[TBL] [Abstract][Full Text] [Related]
8. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
[TBL] [Abstract][Full Text] [Related]
9. Role of Nanotechnology in Diabetic Management.
Siwach R; Pandey P; Chawla V; Dureja H
Recent Pat Nanotechnol; 2019; 13(1):28-37. PubMed ID: 30608045
[TBL] [Abstract][Full Text] [Related]
10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
11. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
DeWitt DE; Hirsch IB
JAMA; 2003 May; 289(17):2254-64. PubMed ID: 12734137
[TBL] [Abstract][Full Text] [Related]
12. Update in the pharmacologic treatment of diabetes mellitus: focus on pramlintide and exenatide.
Odegard PS; Setter SM; Iltz JL
Diabetes Educ; 2006; 32(5):693-712. PubMed ID: 16971704
[TBL] [Abstract][Full Text] [Related]
13. Non-insulin dependent diabetes mellitus: present therapies and new drug targets.
Das SK; Chakrabarti R
Mini Rev Med Chem; 2005 Nov; 5(11):1019-34. PubMed ID: 16307531
[TBL] [Abstract][Full Text] [Related]
14. Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions.
Singh J; Cumming E; Manoharan G; Kalasz H; Adeghate E
Open Med Chem J; 2011; 5(Suppl 2):70-7. PubMed ID: 21966327
[TBL] [Abstract][Full Text] [Related]
15. New frontiers in the management of type 2 diabetes.
Mudaliar S
Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356
[TBL] [Abstract][Full Text] [Related]
16. Insulin therapy in type 2 diabetes.
Mudaliar S; Edelman SV
Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
[TBL] [Abstract][Full Text] [Related]
17. Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus.
Modi P
Curr Drug Discov Technol; 2007 Jun; 4(1):39-47. PubMed ID: 17630927
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in nanotechnology for diabetes treatment.
DiSanto RM; Subramanian V; Gu Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(4):548-64. PubMed ID: 25641955
[TBL] [Abstract][Full Text] [Related]
19. Nanoformulations for the Delivery of Dietary Anthocyanins for the Prevention and Treatment of Diabetes Mellitus and Its Complications.
Nunes AR; Costa EC; Alves G; Silva LR
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242519
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
